Cbre 2025 Life Sciences Outlook

Cbre 2025 Life Sciences Outlook. 2023 U.S. Life Sciences Outlook CBRE Australia On the other hand, global venture capital increased (as did mergers and acquisitions), U.S employment reached record growth, and the industry remains "in a period of unprecedented innovation and discovery," according to CBRE's "U.S

Life Sciences Outlook highlights continued growth driven by key factors such as an improving economy, robust sector employment, and a more favorable capital market environment employment reached record growth, and the industry remains "in a period of unprecedented innovation and discovery," according to CBRE's "U.S

Life Sciences Innovation and Expansion CBRE

The ongoing demand for Life Sciences laboratory space will continue to outstrip supply, yet relief is on the horizon as more projects near completion and enter the market. Find a Property Find a Property CBRE are global leaders in commercial property, both to rent and for sale. Previous cycles show that any slowdown in life sciences employment likely won't be as severe as that of the broader economy

2023 U.S. Life Sciences Outlook CBRE Australia. A surge of new lab/R&D supply will be the life sciences market's biggest challenge in the first half of 2025 before tapering off later in the year Life sciences lab and R&D property sales dropped to their lowest level in more than a decade in 2024, primarily due to high interest rates and weak supply-and-demand fundamentals, according to CBRE

Employment Trends & Outlook CBRE. Life Sciences Outlook provides investors and occupiers alike with valuable insights to where the market is headed this year. Life Sciences Outlook highlights continued growth driven by key factors such as an improving economy, robust sector employment, and a more favorable capital market environment